Energy Fuels Acquires RadTran LLC

NANO Nuclear Energy Acquires Secured Transportation Services (STS) for Up to $13 Million

May 27, 2026

IT Services

NANO Nuclear Energy Inc. acquired Secured Transportation Services LLC (STS), a specialized U.S. nuclear logistics and transportation company, for total consideration valued at up to $13 million. The deal adds fuel transportation and deployment planning capabilities to NANO Nuclear’s vertically integrated microreactor and advanced nuclear platform via its subsidiary Advanced Fuel Transportation Inc.

Radiance Technologies Acquires Phased n Research

March 31, 2025

Aerospace & Defense

Radiance Technologies, a 100% employee‑owned prime contractor based in Huntsville, Alabama, has acquired Phased n Research, a radar and electronic warfare (EW) engineering firm founded in 2018. The deal brings Phasedn’s radar, modeling & simulation, and EW capabilities into Radiance’s portfolio; founder Dr. Bassem Mahafza will move to an emeritus/advisor role and Dr. Mark Tillman will become President of Phasedn to ensure continuity and alignment with Department of Defense modernization efforts.

Radon Medical Imaging Acquires Alpha Imaging

November 19, 2024

Healthcare Services

Radon Medical Imaging, a PE-backed independent service organization, acquired Alpha Imaging of Willoughby, Ohio in an add-on transaction closed in October 2024. The deal expands Radon's geographic footprint and service and distribution capabilities in medical imaging equipment across the eastern U.S.

Oklo Acquires Atomic Alchemy to Secure Domestic Radioisotope Supply

November 15, 2024

Energy

Oklo, the Sam Altman–backed small-reactor developer, is acquiring US radioisotope producer Atomic Alchemy in an all-stock transaction valued at $25 million. The deal will vertically integrate radioisotope and fuel production to secure domestic supplies for Oklo’s reactors and create a complementary revenue stream for medical and industrial isotopes.

AstraZeneca Acquires Fusion Pharmaceuticals

March 19, 2024

Biotechnology

AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage company developing next-generation actinium-based radioconjugates, for $21.00 per share in cash plus a non-transferable contingent value right that could bring the total to approximately $2.4 billion. The acquisition adds Fusion's pipeline (including FPI-2265 for mCRPC), R&D and manufacturing capabilities in radioconjugates and strengthens AstraZeneca's oncology portfolio and presence in Canada.

5th Century Partners Acquires Radon Medical Imaging

December 2, 2022

Healthcare Services

5th Century Partners has acquired Radon Medical Imaging, a provider of medical imaging equipment service, sales, and distribution, with unitranche debt and a minority equity investment provided by Avante Capital Partners to support the transaction. The deal positions Radon as the platform for growth in medical imaging services and will leverage Avante’s flexible capital to support the company’s expansion.